Dr Eleanor Cheadle PhD, BSc (Hons), FHEA

Research Fellow

Full contact details
View graph of relations

Publications

  1. 2020
  2. E-pub ahead of print

    Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response

    Cheng, S., Cheadle, E. J. & Illidge, T. M., 30 Sep 2020, (E-pub ahead of print) In: Cancers. 12, 10, p. 2835

    Research output: Contribution to journalArticlepeer-review

  3. Accepted/In press

    Reprogramming the tumour microenvironment by radiotherapy: Implications for radiotherapy and immunotherapy combinations.

    Colton, M., Cheadle, E., Honeychurch, J. & Illidge, T., 21 Sep 2020, (Accepted/In press) In: Radiation Oncology .

    Research output: Contribution to journalArticlepeer-review

  4. 2019
  5. Published

    Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity

    Cazaux, M., Grandjean, C. L., Lemaître, F., Garcia, Z., Beck, R. J., Milo, I., Postat, J., Beltman, J. B., Cheadle, E. J. & Bousso, P., 2019, In: The Journal of experimental medicine.

    Research output: Contribution to journalArticlepeer-review

  6. 2018
  7. Published
  8. Published

    Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer

    Owens, G., Edmondson, R. & Cheadle, E., Apr 2018, In: Journal of Immunotherapy. 41, 3, p. 130-140 11 p.

    Research output: Contribution to journalArticlepeer-review

  9. 2017
  10. Published

    Fractionated radiation therapy stimulates anti-tumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD1 blockade

    Dovedi, S., Cheadle, E., Popple, A. L., Poon, E., Morrow, M., Stewart, R., Yusko, E. C., Sanders, C. M., Vignali, M., Emerson, R. O., Robins, H. S., Wilkinson, R. W., Honeychurch, J. & Illidge, T., 22 May 2017, In: Clinical Cancer Research. 23, 18, p. 5514–5526

    Research output: Contribution to journalArticlepeer-review

  11. Published

    A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells (vol 31, pg 1611, 2017)

    Cheadle, E. J., Lipowska-Bhalla, G., Dovedi, S. J., Fagnano, E., Klein, C., Honeychurch, J. & Illidge, T. M., 2017, In: Leukemia. 31, 10, p. 2278-2278

    Research output: Contribution to journalArticlepeer-review

  12. Published

    CD19 CAR T-cells expressing IL-12 eradicate lymphoma in fully lymphoreplete mice through induction of host immunity

    Kueberuwa, G., Kalaitsidou, M., Cheadle, E., Hawkins, R. & Gilham, D., 2017, In: Molecular therapy oncolytics.

    Research output: Contribution to journalArticlepeer-review

  13. 2016
  14. Published

    Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CD8+ T cells

    Dovedi, S., Lipowska-Bhalla, G., Beers, S., Cheadle, E., Mu, L., Glennie, M. J., Illidge, T. & Honeychurch, J., 1 Jul 2016, In: Cancer Immunology Research . 4, 7

    Research output: Contribution to journalArticlepeer-review

  15. Published

    Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.

    Dovedi, S. J., Adlard, A., Ota, Y., Murata, M., Sugaru, E., Koga-Yamakawa, E., Eguchi, K., Hirose, Y., Yamamoto, S., Umehara, H., Honeychurch, J., Cheadle, E. J., Hughes, G., Jewsbury, P. J., Wilkinson, R. W., Stratford, I. & Illidge, T. M., 5 Mar 2016, In: Oncotarget. 7, p. 17035-17046

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 Next